retatrutide clinical trial results safety Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a Retatrutide Weight Loss Results:Trial Data
Description
A recent genetic study has provided new insights into how glucagon-like peptide-1 (GLP-1) receptor agonists aid weight loss
$249 per month, no matter the dose
Physician-supervised GLP-1 weight loss with personalized dosing, telehealth visits & home delivery
Learn how they can benefit you!
This medication is available by prescription only
